| GENE_SYMBOL |
HGNC_ID |
UNIPROT_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 22 |
141758409 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 36 |
141758410 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 35 |
141758412 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
(S)-1-Cyano-N-(5-phenylthiazol-2-yl)piperidine-3-carboxamide |
141758417 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 10 |
141758418 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 83 |
141758420 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 25 |
141758424 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
(2R)-4-cyano-N-[5-(1H-pyrazol-5-yl)pyridin-2-yl]morpholine-2-carboxamide |
141758425 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 9 |
141758426 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 19 |
141758429 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 43 |
141758431 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
4-Cyano-N-(5-phenylpyridin-2-yl)morpholine-2-carboxamide |
141758432 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
4-cyano-N-(5-phenyl-1H-pyrazol-3-yl)morpholine-2-carboxamide |
141758433 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 26 |
141758434 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 33 |
141758436 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
(2R)-4-cyano-N-[6-(1H-pyrazol-4-yl)isoquinolin-3-yl]morpholine-2-carboxamide |
141758437 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 14 |
141758438 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
1-cyano-3-fluoro-N-[5-(1H-pyrazol-5-yl)pyridin-2-yl]piperidine-3-carboxamide |
141758442 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
4-Cyano-N-(5-phenylisoxazol-3-yl)morpholine-2-carboxamide |
141758444 |
ChemBL |
| USP30 |
HGNC:20065 |
Q70CQ3 |
US11370784, Example 28 |
141758446 |
ChemBL |